About
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to...
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
  • 25
    Mar
    20
    Corporate Update
    2019 Annual Report on Form 10-K and 2020 Proxy Statement
  • 13
    Aug
    19
    Equity Research
    AbbVie (NYSE:ABBV) Research Update
  • 26
    Jul
    19
    Corporate Update
    AbbVie Reports Second-Quarter 2019 Financial Results
  • 25
    Apr
    19
    News Release
    AbbVie Reports First-Quarter 2019 Financial Results
  • 28
    Mar
    19
    Equity Research
    AbbVie (NYSE:ABBV) Research Update
  • 27
    Feb
    19
    Corporate Update
    2018 Annual Report on Form 10-K and 2019 Proxy Statement
  • 9
    Jan
    19
    Company Presentation
    AbbVie Inc J.P. Morgan 2019 Healthcare Conference
  • 26
    Nov
    18
    Equity Research
    AbbVie (NYSE:ABBV) Research Initiation
  • 7
    Nov
    18
    Corporate Update
    AbbVie Inc Quarterly Report for the period ended 30 September 2018
  • 7
    Aug
    18
    Corporate Update
    AbbVie Inc Quarterly Report for the period ended 30 June 2018
  • 6
    Jun
    18
    Company Presentation
    AbbVie Inc Jefferies 2018 Healthcare Conference Presentation
  • 4
    May
    18
    Corporate Update
    AbbVie Inc Quarterly Report for the period ended 31 March 2018
  • 1
    Apr
    18
    Corporate Update
    ABBV 2017 Annual Report